You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 3, January 15, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Toward Optimal Laboratory Use
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (111)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of a System Using Oral Mucosal Transudate for HIV-1 Antibody Screening and Confirmatory Testing

Dana Gallo; J. Richard George, PhD; John H. Fitchen, MD; Andrew S. Goldstein, MS; Michael S. Hindahl, PhD

JAMA. 1997;277(3):254-258.


Abstract

Objective.
—To determine accuracy of a human immunodeficiency virus type 1 (HIV-1) antibody testing system using a device to collect and stabilize oral mucosal transudate (OMT), a fluid with increased levels of IgG; an enzyme immunoassay (EIA) screening test optimized for OMT; and a Western blot confirmatory test designed for use with OMT.

Design.
—The OMT specimens were tested by EIA and, if indicated, confirmatory Western blot according to a standard testing algorithm. The OMT results were compared with true HIV status as determined by serum testing and/or clinical diagnosis.

Patients.
—Specimens from 3570 subjects (2382 at low risk, 698 at high risk, 242 with acquired immunodeficiency syndrome [AIDS], and 248 "nonspecificity" [persons with diseases associated with an increased frequency of false-positive results in HIV testing]) were collected at 11 geographically diverse sites (including blood banks, public health clinics, general medical clinics, HIV clinics, sexually transmitted disease clinics, and a hemophilia center) in the United States.

Main Outcome Measures.
—Overall accuracy of testing OMT for HIV-1 antibodies compared with true HIV-1 antibody status; sensitivity and specificity of OMT EIA and Western blot.

Results.
—Sensitivity of OMT EIA testing in 673 true-positive subjects was 99.9% (672/673). The OMT Western blot results in the 673 true-positive subjects were positive in 665 and indeterminate in 8. The EIA followed by Western blot (if EIA was repeatedly reactive) yielded a negative result in 99.9% (2893/2897) of OMT samples from true negatives and an indeterminate result in 4. The OMT testing system provided the correct result or would trigger appropriate follow-up testing in 3569 (>99.9%) of 3570 cases.

Conclusion.
—HIV-1 antibody testing of OMT samples is a highly accurate alternative to serum testing.



Author Affiliations

for the OraSure HIV Clinical Trials Group

From the Viral and Rickettsial Disease Laboratory, California State Department of Health Services, Berkeley (Ms Gallo), and Epitope Inc, Beaverton, Ore (Drs George, Fitchen, and Hindahl and Mr Goldstein).


Footnotes

A complete list of the OraSure HIV Clinical Trials Group appears at the end of this article.

At the time of this research, Drs George, Fitchen, and Hindahl and Mr Goldstein had Epitope stock options and stock holdings. All own stock in the company and all, except Dr Hindahl, who is no longer with Epitope, currently have stock options.

Reprints: John H. Fitchen, MD, Epitope Inc, 8505 SW Creekside Place, Beaverton, OR 97008.

Toward Optimal Laboratory Use section editor: George D. Lundberg, MD, Editor, JAMA.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An evaluation of the performance of OraQuick(R) ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK
Zelin et al.
Int J STD AIDS 2008;19:665-667.
ABSTRACT | FULL TEXT  

A study on HIV and hepatitis C virus among commercial sex workers in Tallinn
Uuskula et al.
Sex. Transm. Infect. 2008;84:189-191.
ABSTRACT | FULL TEXT  

Geographic Distribution of Human Immunodeficiency Virus in South Africa
Kleinschmidt et al.
Am J Trop Med Hyg 2007;77:1163-1169.
ABSTRACT | FULL TEXT  

Effects of Sex Work on the Prevalence of Syphilis Among Injection Drug Users in 3 Russian Cities
Platt et al.
AJPH 2007;97:478-485.
ABSTRACT | FULL TEXT  

Prevalence of HIV Infection Among Young Adults in the United States: Results From the Add Health Study
Morris et al.
AJPH 2006;96:1091-1097.
ABSTRACT | FULL TEXT  

(C2) Saliva, Breast Milk, and Mucosal Fluids in HIV Transmission
Page-Shafer et al.
ADR 2006;19:152-157.
ABSTRACT | FULL TEXT  

Screening for HIV: Recommendation Statement
U.S. Preventive Services Task Force*
ANN INTERN MED 2005;143:32-37.
ABSTRACT | FULL TEXT  

Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou et al.
ANN INTERN MED 2005;143:55-73.
ABSTRACT | FULL TEXT  

Diagnosis of Norwalk Virus Infection by Indirect Enzyme Immunoassay Detection of Salivary Antibodies to Recombinant Norwalk Virus Antigen
Moe et al.
CVI 2004;11:1028-1034.
ABSTRACT | FULL TEXT  

Using Peer Recruitment and OraSure to Increase HIV Testing
Vargo et al.
AJPH 2004;94:29-31.
ABSTRACT | FULL TEXT  

STI services in the United Kingdom: how shall we cope?
Bradbeer and Mears
Sex. Transm. Infect. 2003;79:435-438.
FULL TEXT  

Human Papillomavirus-Specific Antibody Status in Oral Fluids Modestly Reflects Serum Status in Human Immunodeficiency Virus-Positive Individuals
Cameron et al.
CVI 2003;10:431-438.
ABSTRACT | FULL TEXT  

THE DIAGNOSTIC APPLICATIONS OF SALIVA-- A REVIEW
Kaufman and Lamster
CROBM 2002;13:197-212.
ABSTRACT | FULL TEXT  

Influence of Host Factors on Immunoglobulin G Concentration in Oral Fluid Specimens
Granade et al.
CVI 2002;9:194-197.
ABSTRACT | FULL TEXT  

Increasing Voluntary HIV Testing by Offering Oral Tests in Incarcerated Populations
Bauserman et al.
AJPH 2001;91:1226-1229.
ABSTRACT | FULL TEXT  

Validation of a Modified Commercial Enzyme-Linked Immunoassay for Detection of Human Immunodeficiency Virus Type 1 Immunoglobulin G Antibodies in Saliva
Chohan et al.
CVI 2001;8:346-348.
ABSTRACT | FULL TEXT  

A Simple Saliva-Based Test for Detecting Antibodies to Human Immunodeficiency Virus
Schramm et al.
CVI 1999;6:577-580.
ABSTRACT | FULL TEXT  

Detection of Human Immunodeficiency Virus Antibodies in Oral Fluids
Hodinka et al.
CVI 1998;5:419-426.
FULL TEXT  

Detection of Antibodies to Human Immunodeficiency Virus Type 1 in Oral Fluids: A Large-Scale Evaluation of Immunoassay Performance
Granade et al.
CVI 1998;5:171-175.
ABSTRACT | FULL TEXT  

Usefulness of Oral Mucosal Transudate for HIV Antibody Testing
Ryder
JAMA 1997;277:1591-1591.
ABSTRACT  

Usefulness of Oral Mucosal Transudate for HIV Antibody Testing
Martinez et al.
JAMA 1997;277:1592-1592.
ABSTRACT  

Usefulness of Oral Mucosal Transudate for HIV Antibody Testing
Tessler and Walsh
JAMA 1997;277:1591-1591.
ABSTRACT  

Usefulness of Oral Mucosal Transudate for HIV Antibody Testing
Frank
JAMA 1997;277:1591-1592.
ABSTRACT  

Testing Oral Secretions for HIV
AIDS Clin Care 1997;1997:4-4.
FULL TEXT  

HIV TESTING WITHOUT NEEDLES
JWatch General 1997;1997:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.